(VIANEWS) – Consolidated Water Co. Ltd. (CWCO), Apollo Medical Holdings (AMEH), Middlesex Water Company (MSEX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Consolidated Water Co. Ltd. (CWCO)
22.8% sales growth and 9.19% return on equity
Consolidated Water Co. Ltd., together with its subsidiaries, designs, constructs, manages, and operates water production and water treatment plants primarily in the Cayman Islands, the Bahamas, and the United States. The company operates through four segments: Retail, Bulk, Services, and Manufacturing. It uses reverse osmosis technology to produce potable water from seawater. The company produces and supplies water to end-users, including residential, commercial, and government customers, as well as government-owned distributors. It also provides design, engineering, construction, procurement, and management services for desalination projects and water treatment plants, as well as management and engineering services relating to municipal water distribution and treatment. In addition, the company manufactures and services a range of water-related products, including reverse osmosis desalination equipment, membrane separation equipment, filtration equipment, piping systems, vessels, and custom fabricated components; and provides design, engineering, consulting, management, inspection, training, and equipment maintenance services for commercial, municipal, and industrial water production, supply, and treatment, as well as desalination and wastewater treatment. Consolidated Water Co. Ltd. was incorporated in 1973 and is headquartered in Grand Cayman, the Cayman Islands.
Earnings Per Share
As for profitability, Consolidated Water Co. Ltd. has a trailing twelve months EPS of $0.93.
PE Ratio
Consolidated Water Co. Ltd. has a trailing twelve months price to earnings ratio of 31.01. Meaning, the purchaser of the share is investing $31.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.19%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Sep 28, 2023, the estimated forward annual dividend rate is 0.35 and the estimated forward annual dividend yield is 1.19%.
Yearly Top and Bottom Value
Consolidated Water Co. Ltd.’s stock is valued at $28.84 at 01:22 EST, under its 52-week high of $31.85 and way higher than its 52-week low of $13.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 110%, now sitting on 130.59M for the twelve trailing months.
Previous days news about Consolidated Water Co. Ltd.(CWCO)
- According to Zacks on Tuesday, 10 October, "A few other top-ranked stocks in the same industry are Consolidated Water Co. Ltd. "
- According to Zacks on Wednesday, 11 October, "Corp. (VIRC Quick QuoteVIRC – Free Report) , LSI Industries Inc. (LYTS Quick QuoteLYTS – Free Report) , Consolidated Water Co. Ltd. "
2. Apollo Medical Holdings (AMEH)
19.8% sales growth and 9.55% return on equity
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Earnings Per Share
As for profitability, Apollo Medical Holdings has a trailing twelve months EPS of $1.07.
PE Ratio
Apollo Medical Holdings has a trailing twelve months price to earnings ratio of 28.83. Meaning, the purchaser of the share is investing $28.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.55%.
Volume
Today’s last reported volume for Apollo Medical Holdings is 138321 which is 21.52% below its average volume of 176266.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.1%, now sitting on 1.3B for the twelve trailing months.
3. Middlesex Water Company (MSEX)
12.8% sales growth and 9.29% return on equity
Middlesex Water Company owns and operates regulated water utility and wastewater systems. It operates in two segments, Regulated and Non-Regulated. The Regulated segment collects, treats, and distributes water on a retail and wholesale basis to residential, commercial, industrial, and fire protection customers in parts of New Jersey, Delaware, and Pennsylvania. This segment also includes regulated wastewater systems in New Jersey and Delaware. The Non-Regulated segment provides non-regulated contract services for the operation and maintenance of municipal and private water and wastewater systems in New Jersey and Delaware. The company was incorporated in 1896 and is headquartered in Iselin, New Jersey.
Earnings Per Share
As for profitability, Middlesex Water Company has a trailing twelve months EPS of $2.09.
PE Ratio
Middlesex Water Company has a trailing twelve months price to earnings ratio of 31.7. Meaning, the purchaser of the share is investing $31.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.29%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 167.51M for the twelve trailing months.
4. Flowserve Corporation (FLS)
12.2% sales growth and 13.64% return on equity
Flowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. It operates in two segments, Flowserve Pump Division (FPD) and Flow Control Division (FCD). The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, re-rate and upgrade solutions, retrofit programs, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. The FCD segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls, and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs, and field machining capabilities. This segment's products are used to control, direct, and manage the flow of liquids, gases, and fluids. The company primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Flowserve Corporation has a trailing twelve months EPS of $1.81.
PE Ratio
Flowserve Corporation has a trailing twelve months price to earnings ratio of 21.24. Meaning, the purchaser of the share is investing $21.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.64%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 20, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 2.12%.
Moving Average
Flowserve Corporation’s worth is below its 50-day moving average of $38.97 and above its 200-day moving average of $35.50.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 3.97B for the twelve trailing months.
Volume
Today’s last reported volume for Flowserve Corporation is 1205220 which is 16.35% above its average volume of 1035810.
5. Royalty Pharma (RPRX)
10.8% sales growth and 4.66% return on equity
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $0.55.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 49.13. Meaning, the purchaser of the share is investing $49.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.66%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Royalty Pharma’s EBITDA is 46.14.
Yearly Top and Bottom Value
Royalty Pharma’s stock is valued at $27.02 at 01:22 EST, way below its 52-week high of $44.47 and above its 52-week low of $25.92.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 2.36B for the twelve trailing months.
Previous days news about Royalty Pharma(RPRX)
- According to Zacks on Thursday, 12 October, "Investors interested in Financial – Miscellaneous Services stocks are likely familiar with Royalty Pharma (RPRX Quick QuoteRPRX – Free Report) and Brookfield Asset Management (BAM Quick QuoteBAM – Free Report) . ", "Currently, Royalty Pharma has a Zacks Rank of #2 (Buy), while Brookfield Asset Management has a Zacks Rank of #4 (Sell). "
6. Regional Management Corp. (RM)
8.8% sales growth and 8.76% return on equity
Regional Management Corp., a diversified consumer finance company, provides various installment loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders in the United States. It offers small and large installment loans; and retail loans to finance the purchase of furniture, appliances, and other retail products. The company also provides insurance products, including credit life, credit accident and health, credit property, vehicle single interest, and credit involuntary unemployment insurance; collateral protection insurance; and property insurance, as well as reinsurance products. In addition, its loans are sourced through branches, centrally managed direct mail campaigns, digital partners, and retailers, as well as its consumer website. As of February 24, 2022, the company operated through a network of approximately 350 branches in 14 states. Regional Management Corp. was incorporated in 1987 and is headquartered in Greer, South Carolina.
Earnings Per Share
As for profitability, Regional Management Corp. has a trailing twelve months EPS of $2.89.
PE Ratio
Regional Management Corp. has a trailing twelve months price to earnings ratio of 8.86. Meaning, the purchaser of the share is investing $8.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.76%.
Moving Average
Regional Management Corp.’s worth is under its 50-day moving average of $27.95 and way below its 200-day moving average of $29.22.
Yearly Top and Bottom Value
Regional Management Corp.’s stock is valued at $25.61 at 01:22 EST, way below its 52-week high of $38.34 and above its 52-week low of $24.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.7%, now sitting on 516.84M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 21, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 4.51%.
7. Brown & Brown (BRO)
8% sales growth and 15.65% return on equity
Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, Cayman Islands, Ireland, and the United Kingdom. It operates through four segments: Retail, National Programs, Wholesale Brokerage, and Services. The company offers builders risk, group medical and pharmaceutical, property, commercial auto, homeowners, reinsurance, crop and hail, inland marine, retirement benefit, cyber, disability, risk mitigating warranty products, directors and officers, management liability, errors and omissions, medical stop loss, term life, excess liability, personal auto, umbrella, general liability, prescription drug, workers compensation, and group dental insurance products. It also provides professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, and real estate title professionals, as well as supplementary insurance-related products for weddings, events, medical facilities, and cyber liability; homeowners and personal property policies, residential earthquake, and private passenger automobile and motorcycle coverage; commercial and public entity-related programs; and flood insurance, commercial difference-in-conditions, all-risk commercial property, coastal property programs, lender-placed solutions, sovereign Indian nations, and parcel insurance. In addition, it provides markets and sells excess and surplus commercial insurance products, such as personal lines, homeowners, yachts, jewelry, commercial property and casualty, commercial automobile, garage, restaurant, builder's risk, and inland marine lines; and third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, as well as Medicare Set-aside, Social Security disability, Medicare benefits advocacy, and claims adjusting services. The company was founded in 1939 and is headquartered in Daytona Beach, Florida.
Earnings Per Share
As for profitability, Brown & Brown has a trailing twelve months EPS of $2.6.
PE Ratio
Brown & Brown has a trailing twelve months price to earnings ratio of 27.32. Meaning, the purchaser of the share is investing $27.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.65%.
Previous days news about Brown & Brown(BRO)
- According to Zacks on Tuesday, 10 October, "Also, these strategic buyouts help Brown & Brown increase commissions and fees, which, in turn, drive revenues. ", "Consistent operational results have been aiding Brown & Brown in generating solid cash flows for deployment in strategic initiatives. "
8. CBIZ (CBZ)
6.6% sales growth and 15.06% return on equity
CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. The company operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segment offers accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services. The Benefits and Insurance Services provides group health benefits consulting, payroll, property and casualty, and retirement plan services. The National Practices segment offers managed networking and hardware, and health care consulting services. It primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. The company was founded in 1987 and is headquartered in Cleveland, Ohio.
Earnings Per Share
As for profitability, CBIZ has a trailing twelve months EPS of $2.35.
PE Ratio
CBIZ has a trailing twelve months price to earnings ratio of 22.92. Meaning, the purchaser of the share is investing $22.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.06%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 1.51B for the twelve trailing months.
Volume
Today’s last reported volume for CBIZ is 257991 which is 20.41% above its average volume of 214246.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CBIZ’s EBITDA is 61.38.
Yearly Top and Bottom Value
CBIZ’s stock is valued at $53.86 at 01:22 EST, under its 52-week high of $56.96 and way above its 52-week low of $42.87.
